Myco-Minds Institute
Myco-Minds Institute
Published 4/2023
MP4 | Video: h264, 1280x720 | Audio: AAC, 44.1 KHz
Language: English | Size: 470.94 MB | Duration: 4h 0m
A Psilocybin Session Facilitator Training for Licensed Professionals
What you'll learn
Understand the current state of research on psilocybin therapy, including its history, potential benefits, and limitations
Explore administration of psilocybin in therapy including their effects on the brain and mind
Gain a historical perspective on the use of psilocybin, including its traditional use in indigenous cultures and its emergence in the Western world
Analyze the therapeutic frameworks and approaches used in psilocybin facilitation, such as set and setting, integration, and preparation and aftercare.
Evaluate the ethical and legal considerations related to psilocybin facilitation, including the role of the facilitator, patient safety, and potential barriers
Analyze the existing research on the effectiveness of psilocybin-assisted therapy for treating mental health disorders.
Apply knowledge of the principles and practices of psilocybin assisted therapy to create treatment plans and protocols for clients.
Requirements
Must be 21 years or over
Must be currently licensed as a psychiatrist, psychologist, counselor, therapist, social worker, doctor, nurse, home health aid or other healthcare worker
The online component of this program is self-directed, and at your own pace, but you can reach out to our educators at any point you need assistance, as well as discuss and network with other students through sharing your writing assignments
Description
Welcome to Myco-Minds Institute! This comprehensive program uses Myco-Method, an Oregon Health Authority-approved Psilocybin Facilitator Training Program curriculum to provide in-depth education to professionally licensed healthcare and mental healthcare workers seeking to become competent and responsible psilocybin facilitators. The full Facilitator Training Program component of Myco-Minds Institute has received approval to provide the training required for licensure of facilitators in Oregon. As psilocybin-assisted therapy gains recognition as a viable treatment for mental health conditions, the need for properly trained and qualified facilitators is increasing. Our program aims to provide a rigorous and well-rounded training that will equip licensed healthcare professionals with the necessary knowledge, skills, and ethical guidelines to facilitate psilocybin sessions safely and effectively.Myco-Minds Institute's Facilitator Training Program requires a total of 160 hours of instruction, which includes in-person training, online training, and practicum study.The online training component consists of 60 hours of instruction, which provides students with flexibility in their learning and allows them to progress through the material at their own pace. It is anticipated it will take approximately 4-6 months to complete. The online training includes articles, essays, lectures, videos, poems, demonstrations, quizzes, and writing assignments, providing a comprehensive exploration of the material. Further, although the online course is self-paced, participants still have the opportunity to connect with instructors and others in their learning cohort, through sharing their writing assignments and providing feedback to others as they move through the course.For those looking to complete the full Facilitator Training Program, additional requirements include an in-person residency and a practicum. The in-person training component consists of 60-hours of immersive learning experience with other experienced facilitators and students. This portion of the training includes lectures, interactive discussions, and experiential learning opportunities, allowing students to develop their skills and knowledge in a collaborative and supportive environment.The practicum component consists of an additional 40 hours of supervised learning in practicum, which allows students to deepen their understanding of the material and apply their knowledge in practical ways. Students will have access to resources and support to facilitate their learning and ensure they are meeting the requirements of the program.Through this comprehensive and rigorous training program, students will develop the knowledge and skills necessary to become competent and compassionate psilocybin session facilitators.
Overview
Section 1: Introduction
Lecture 1 Myco-Minds Institute Introduction
Lecture 2 Meet the Instructors: Shasta
Lecture 3 Meet the Instructors: Karlene
Lecture 4 Meet the Instructors: Dodi
Lecture 5 Meet the Instructors: Campton
Lecture 6 Overview of Myco-Minds Institute
Lecture 7 Program Components
Lecture 8 Objectives and Learning Outcomes
Lecture 9 Ethical and Legal considerations
Section 2: Foundations of Psychedelic Therapy
Lecture 10 Introduction to psychedelic-assisted therapy
Lecture 11 History of psychedelic therapy and research
Lecture 12 Theoretical frameworks and models of psychedelic therapy
Section 3: Historical, Traditional, and Contemporary Practices and Applications
Lecture 13 Historical, Traditional Use and Contemporary Practices Video
Lecture 14 Current and Historical Use
Lecture 15 The Controlled Substances Act
Lecture 16 Overview of historical and present research
Section 4: Cultural Equity in Relation to Psilocybin Services
Lecture 17 Intro to Cultural Equity Video
Lecture 18 Cultural Equity in Psilocybin Services
Lecture 19 Racial Justice
Lecture 20 The Impact of Drug Policy
Lecture 21 History of Systemic Inequality
Lecture 22 Intergenerational trauma
Lecture 23 Responsible Referral and Support
Section 5: Safety, Ethics, Law and Responsibilities
Lecture 24 Intro to Safety, Ethics, the Law and Responsibility Video
Lecture 25 Prohibited Conduct
Lecture 26 Awareness of Facilitator Bias
Lecture 27 Intro to Measure 109 Video
Lecture 28 The Oregon Psilocybin Services Act
Lecture 29 Oregon's Facilitator Code of Ethics
Lecture 30 Intro to Boundaries for Psilocybin Facilitators Video
Lecture 31 Ethical considerations relating to equity, privilege, bias and power
Lecture 32 Awareness of increased vulnerability
Lecture 33 Appropriate use of touch and client consent to physical contact
Lecture 34 Appropriate emotional and sexual boundaries
Lecture 35 Financial conflicts of interest
Lecture 36 Advertising Restrictions
Lecture 37 Intro to Scope of Practice for Psilocybin Facilitators Video
Lecture 38 Reasonable expectations regarding client outcomes
Lecture 39 Accurate record keeping and client confidentiality
Lecture 40 Awareness of new research
Lecture 41 Risk Mitigation
Section 6: Psilocybin Pharmacology, Neuroscience, and Clinical Research
Lecture 42 Intro to Psilocybin Pharmacology Video
Lecture 43 Campton's Conceptualization: Neurogenesis
Lecture 44 Pharmacodynamics and pharmacokinetics of psilocybin
Lecture 45 Metabolism of Psilocybin
Lecture 46 Drug and supplement interaction
Lecture 47 Effects on brain and neurotransmitter systems
Lecture 48 The Neuroscience of Psilocybin
Lecture 49 Key areas of psilocybin research
Lecture 50 Models of substance use, addiction, and recovery
Lecture 51 Chemical Properties
Lecture 52 Physiological effects
Lecture 53 Risk reduction strategies
Lecture 54 Legal and regulatory issues
Section 7: Psychological Effects of Psilocybin
Lecture 55 Introduction to the Psychological Effects of Psilocybin
Lecture 56 Subjective experiences and effects of psilocybin
Lecture 57 Models of the mind and self
Lecture 58 Spiritual and mystical experiences
Lecture 59 Emotional processing and therapeutic potential
Lecture 60 The Psychedelic Experience
Section 8: Core Facilitation Skills
Lecture 61 Intro to Core Facilitation Skills Video
Lecture 62 Building Rapport
Lecture 63 Setting Intentions
Lecture 64 Risk and Benefit Assessment
Lecture 65 Confidentiality
Lecture 66 Intro to Difficult Experiences Video
Lecture 67 Managing Difficult experiences
Lecture 68 Boundaries for Facilitators
Lecture 69 Intro to Set and Setting Video
Lecture 70 Set and Setting
Lecture 71 Client communication
Lecture 72 Physical reactions and side effects of psilocybin
Lecture 73 Addressing Adverse Reactions
Lecture 74 Trauma informed care
Lecture 75 Uniqueness of Terminal Illness
Lecture 76 Legal and ethical professionalism
Section 9: Preparation and Orientation
Lecture 77 Intro to Preparation Video
Lecture 78 The Preparation Process
Lecture 79 Preparation
Lecture 80 Informed Consent
Lecture 81 Oregon Informed Consent
Lecture 82 Client Intake & Interview
Lecture 83 Interpreters & Client Support Persons
Lecture 84 Transportation Plans
Lecture 85 Referral to specialized treatment services
Lecture 86 Role of the facilitator in supporting the client
Lecture 87 Scope of Practice
Lecture 88 Trauma informed communication
Lecture 89 Identification of client safety concerns
Lecture 90 Strategies to discuss client safety concerns
Lecture 91 Determination
Lecture 92 Safety Planning
Lecture 93 Boundaries
Lecture 94 Racial and cultural dynamics
Lecture 95 Historical and indigenous modalities of preparation
Section 10: Administration
Lecture 96 Intro to Administration Sessions Video
Lecture 97 Administration Sessions
Lecture 98 Set and Setting
Lecture 99 Dosing Strategies and Considerations
Lecture 100 Experiences on differing dosages
Lecture 101 Physiological considerations
Lecture 102 Delivery mechanisms
Lecture 103 Secondary Doses
Lecture 104 Challenging Behaviors
Lecture 105 Unexpected client disclosures
Lecture 106 Substance-induced psychosis
Lecture 107 Suicidality
Lecture 108 Manifestation of Traumatic Stress
Lecture 109 Trauma's relationship to the body
Lecture 110 Repressed trauma
Lecture 111 Traumatic stress from systemic oppression
Lecture 112 Safety for trauma resolution
Lecture 113 Facilitator Safety Protocols
Lecture 114 Psilocybin Journey Experience Narrative 1
Lecture 115 Psilocybin Journey Experience Narrative 2
Lecture 116 Psilocybin Journey Experience Narrative 3
Lecture 117 Psilocybin Journey Experience Narrative 4
Lecture 118 Psilocybin Journey Experience Narrative 5
Lecture 119 Psilocybin Journey Experience Narrative 6
Lecture 120 Psilocybin Journey Experience Narrative 7
Lecture 121 Psilocybin Journey Experience Narrative 8
Section 11: Integration
Lecture 122 Intro to Integration Sessions Video
Lecture 123 Integration and post-session experiences
Lecture 124 Interpreting feelings and emotions
Lecture 125 Facilitation of positive changes
Lecture 126 Enhancement of existing supportive relationships
Lecture 127 Identification of client safety concerns
Lecture 128 Integration in Clinical Settings
Lecture 129 Facilitator scope of practice
Section 12: Group Facilitation
Lecture 130 Intro to Group Facilitation Video
Lecture 131 Group Preparation Sessions
Lecture 132 Assessing client's compatibility
Lecture 133 Set and setting for groups
Lecture 134 Group agreements
Lecture 135 Group Administration Sessions
Lecture 136 Facilitating group dynamics
Lecture 137 Identifying when removal is needed
Lecture 138 Group Integration Sessions
Lecture 139 Regulatory requirements for group facilitation
Section 13: Next Steps
Lecture 140 Self-Care and Burnout Prevention
Lecture 141 Residency & Continuing Education
Lecture 142 Residency Video
Lecture 143 Supervision
Section 14: FINAL
This comprehensive curriculum is designed to provide in-depth education and training for licensed professionals seeking to become competent and responsible psilocybin facilitators.,This course for licensed healthcare and mental health workers who are interested in learning about psilocybin and its potential therapeutic applications. It aims to provide participants with a comprehensive understanding of psilocybin, including its history, pharmacology, therapeutic uses, and legal status.,This course is designed to meet the requirements for psilocybin facilitators to be licensed in the state of Oregon, in accordance with the regulations outlined in ORS chapter 475A
HOMEPAGE
https://www.udemy.com/course/myco-minds-institute/ DOWNLOAD
https://rapidgator.net/file/18e0587c49e9333f7339aff45435f152/MycoMinds_Institute.rar.html
https://uploadgig.com/file/download/37c16cc881a26685/MycoMinds_Institute.rar
https://uploadgig.com/file/download/37c16cc881a26685/MycoMinds_Institute.rar
